521 related articles for article (PubMed ID: 16206362)
1. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
Wells GA; Boers M; Shea B; Brooks PM; Simon LS; Strand CV; Aletaha D; Anderson JJ; Bombardier C; Dougados M; Emery P; Felson DT; Fransen J; Furst DE; Hazes JM; Johnson KR; Kirwan JR; Landewé RB; Lassere MN; Michaud K; Suarez-Almazor M; Silman AJ; Smolen JS; Van der Heijde DM; van Riel PL; Wolfe F; Tugwell PS
J Rheumatol; 2005 Oct; 32(10):2016-24. PubMed ID: 16206362
[TBL] [Abstract][Full Text] [Related]
2. Residual minimal disease activity in rheumatoid arthritis: a simple definition through an in-depth statistical analysis of the major outcome.
Pietrapertosa D; Salaffi F; Peluso G; Bosello SL; Fedele AL; Cuoghi I; Michelutti A; Gremese E; Ferraccioli GF
Rheumatology (Oxford); 2009 Oct; 48(10):1242-6. PubMed ID: 19635732
[TBL] [Abstract][Full Text] [Related]
3. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
[TBL] [Abstract][Full Text] [Related]
4. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
[TBL] [Abstract][Full Text] [Related]
5. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee.
Goldsmith CH; Boers M; Bombardier C; Tugwell P
J Rheumatol; 1993 Mar; 20(3):561-5. PubMed ID: 8478874
[TBL] [Abstract][Full Text] [Related]
6. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?
Soubrier M; Zerkak D; Gossec L; Ayral X; Roux C; Dougados M
J Rheumatol; 2006 Jul; 33(7):1243-6. PubMed ID: 16622906
[TBL] [Abstract][Full Text] [Related]
7. Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis.
Sokka T; Mäkinen H; Hannonen P; Pincus T
Rheumatology (Oxford); 2007 Jun; 46(6):1020-3. PubMed ID: 17405761
[TBL] [Abstract][Full Text] [Related]
8. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
Felson DT; Smolen JS; Wells G; Zhang B; van Tuyl LH; Funovits J; Aletaha D; Allaart CF; Bathon J; Bombardieri S; Brooks P; Brown A; Matucci-Cerinic M; Choi H; Combe B; de Wit M; Dougados M; Emery P; Furst D; Gomez-Reino J; Hawker G; Keystone E; Khanna D; Kirwan J; Kvien TK; Landewé R; Listing J; Michaud K; Martin-Mola E; Montie P; Pincus T; Richards P; Siegel JN; Simon LS; Sokka T; Strand V; Tugwell P; Tyndall A; van der Heijde D; Verstappen S; White B; Wolfe F; Zink A; Boers M
Ann Rheum Dis; 2011 Mar; 70(3):404-13. PubMed ID: 21292833
[TBL] [Abstract][Full Text] [Related]
9. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
Sokka T; Pincus T
J Rheumatol; 2003 Jun; 30(6):1138-46. PubMed ID: 12784382
[TBL] [Abstract][Full Text] [Related]
10. Rationale and strategies for reevaluating the ACR20.
Felson DT; Furst DE; Boers M
J Rheumatol; 2007 May; 34(5):1184-7. PubMed ID: 17477484
[TBL] [Abstract][Full Text] [Related]
11. Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group).
Bingham CO; Pohl C; Woodworth TG; Hewlett SE; May JE; Rahman MU; Witter JP; Furst DE; Strand CV; Boers M; Alten RE
J Rheumatol; 2009 Oct; 36(10):2335-41. PubMed ID: 19684147
[TBL] [Abstract][Full Text] [Related]
12. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
El Miedany Y; Youssef SS; El Gaafary M
J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis.
Magni-Manzoni S; Ruperto N; Pistorio A; Sala E; Solari N; Palmisani E; Cugno C; Bozzola E; Martini A; Ravelli A
Arthritis Rheum; 2008 Aug; 59(8):1120-7. PubMed ID: 18668599
[TBL] [Abstract][Full Text] [Related]
14. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis.
Wolfe F; Rasker JJ; Boers M; Wells GA; Michaud K
Arthritis Rheum; 2007 Aug; 57(6):935-42. PubMed ID: 17665487
[TBL] [Abstract][Full Text] [Related]
15. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.
Yazici Y; Bergman M; Pincus T
J Rheumatol; 2008 Apr; 35(4):603-9. PubMed ID: 18322993
[TBL] [Abstract][Full Text] [Related]
16. Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?
Mäkinen H; Kautiainen H; Hannonen P; Sokka T
Ann Rheum Dis; 2005 Oct; 64(10):1410-3. PubMed ID: 15941836
[TBL] [Abstract][Full Text] [Related]
17. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study.
Burmester GR; Ferraccioli G; Flipo RM; Monteagudo-Sáez I; Unnebrink K; Kary S; Kupper H
Arthritis Rheum; 2008 Jan; 59(1):32-41. PubMed ID: 18163417
[TBL] [Abstract][Full Text] [Related]
18. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
[TBL] [Abstract][Full Text] [Related]
19. Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis.
Balsa A; Carmona L; González-Alvaro I; Belmonte MA; Tena X; Sanmartí R;
J Rheumatol; 2004 Jan; 31(1):40-6. PubMed ID: 14705217
[TBL] [Abstract][Full Text] [Related]
20. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.
American College of Rheumatology Committee to Reevaluate Improvement Criteria
Arthritis Rheum; 2007 Mar; 57(2):193-202. PubMed ID: 17330293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
